CEMI - Chembio Diagnostics GAAP EPS of -$0.29 misses by $0.08 revenue of $18.82M beats by $7.02M May, 05 2022 04:19 PM Chembio Diagnostics Inc. Chembio Diagnostics press release (NASDAQ:CEMI): Q1 GAAP EPS of -$0.29 misses by $0.08. Revenue of $18.82M (+115.8% Y/Y) beats by $7.02M. For further details see: Chembio Diagnostics GAAP EPS of -$0.29 misses by $0.08, revenue of $18.82M beats by $7.02M